Table 2 Individual predicted LV infarct (%) before and after treatment
ID | Predicted LV infarct (%) | Follow-up period (months) | |
|---|---|---|---|
Pre-treatment | Post-treatment | ||
Subject 01 | 3 | 9 | 15 |
Subject 02 | 6 | 6 | 15 |
Subject 03 | 18 | 18 | 16 |
Subject 04 | 0 | 0 | 18 |
Subject 05 | 6 | 9 | 20 |
Subject 06 | 0 | 9 | 21 |
Subject 07 | 3 | 6 | 21 |
Subject 08 | 9 | 0 | 20 |
Subject 09 | 0 | 6 | 13 |
Subject 10 | 0 | 6 | 18 |
Subject 11 | 0 | 0 | 17 |
Subject 12 | 0 | 0 | 16 |
Subject 13 | 0 | 18 | 17 |
Subject 14 | 0 | 9 | 15 |
Subject 15 | 3 | 0 | 14 |
Subject 16 | 6 | 6 | 14 |
Subject 17 | 3 | 18 | 12 |
Subject 18 | 0 | 6 | 15 |
Subject 19 | 0 | 6 | 19 |
Subject 20 | 9 | 18 | 18 |
Subject 21 | 0 | 0 | 17 |
Subject 22 | 12 | 6 | 18 |
Subject 23 | 0 | 12 | 14 |
Subject 24 | 0 | 9 | 20 |
Subject 25 | 0 | 0 | 23 |
Subject 26 | 0 | 0 | 20 |
Subject 27 | 9 | 24 | 18 |
Subject 28 | 0 | 15 | 12 |
Subject 29 | 9 | 6 | 16 |
Subject 30 | 3 | 6 | 18 |
Subject 31 | 3 | 12 | 13 |